Nantahala Capital Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.9M | Buy |
1,655,689
+812,200
| +96% | +$5.83M | 0.47% | 33 |
|
|
2025
Q1 | $5.05M | Sell |
843,489
-9,366
| -1% | -$56.1K | 0.2% | 58 |
|
|
2024
Q4 | $6.65M | Buy |
852,855
+61,919
| +8% | +$483K | 0.29% | 56 |
|
|
2024
Q3 | $8.54M | Hold |
790,936
| – | – | 0.43% | 38 |
|
|
2024
Q2 | $6.67M | Hold |
790,936
| – | – | 0.39% | 44 |
|
|
2024
Q1 | $5.32M | Buy |
790,936
+150,000
| +23% | +$1.01M | 0.3% | 49 |
|
|
2023
Q4 | $3.77M | Buy |
640,936
+65,936
| +11% | +$388K | 0.23% | 62 |
|
|
2023
Q3 | $5.61M | Buy |
575,000
+510,868
| +797% | +$4.98M | 0.48% | 41 |
|
|
2023
Q2 | $759K | Buy |
+64,132
| New | +$759K | 0.07% | 85 |
|